Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs infliximab for steroid-free remission in moderate to severe Crohn's disease
2008-004926-18Phase 4Completed
- Sponsor
- IBD Center LMU Munich
- Start
- Oct 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of adalimumab and infliximab in Crohn's disease (2 arms), sponsored by IBD Center LMU Munich. Started Oct 2008; status: completed.
02
Drugs
adalimumabinfliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2008-004926-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004926-18.